Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03485729
Title ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Oncoceutics, Inc.
Indications

uterine carcinosarcoma

endometrial cancer

Therapies

ONC201

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers, The State University of New Jersey New Brunswick New Jersey 08903 United States Details
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field